Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
130000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of Series 1 stock acquisition rights with exercise price adjustment clauses issued through a third-party allotment
発行・処分する株式数
130,000 new shares (number of shares delivered since the beginning of the month, from 1 May to 26 May 2026)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
Subject to exercise price adjustment clauses. The exercise price on each exercise date ranges from ¥211 to ¥244. Floor for adjustments: Not disclosed
Number of Stock Acquisition Rights
Total issued: 9,860 rights; exercised since the beginning of the month: 1,300 rights; currently unexercised: 5,650 rights
Most recent equity financing
Timing 24 February 2026 / Type Issuance of new shares and Series 1 stock acquisition rights with exercise price adjustment clauses through a third-party allotment / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of Series 1 stock acquisition rights with exercise price adjustment clauses issued through a third-party allotment |
| Number of shares to be issued or disposed of | 130,000 new shares (number of shares delivered since the beginning of the month, from 1 May to 26 May 2026) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Total number of issued shares | 7,744,350 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | Subject to exercise price adjustment clauses. The exercise price on each exercise date ranges from ¥211 to ¥244. Floor for adjustments: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 9,860 rights; exercised since the beginning of the month: 1,300 rights; currently unexercised: 5,650 rights |
| Most recent equity financing | Timing 24 February 2026 / Type Issuance of new shares and Series 1 stock acquisition rights with exercise price adjustment clauses through a third-party allotment / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose was to inform investors of the large-scale exercise of these stock acquisition rights. No other reason was stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.